RN3161: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving RN3161

• Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity
  NCT07245771 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve RN3161?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.